On May 21, during the 71st World Health Assembly, member states adopted a new digital health resolution. It urges member states to better utilize digital technologies as a means of promoting equitable, affordable universal health coverage (UHC), including reaching vulnerable populations. The resolution also calls on members to analyze the implications of digital health to achieve health related sustainable development goals.
Management Sciences for Health (MSH), a nonprofit global health organization dedicated to saving lives and improving the health of some of the world’s most vulnerable people, today launched MedSource, a private commercial group purchasing organization (GPO) based in Kenya. The launch is part of MSH’s new global initiative that aims to improve health ecosystems by making quality medicines more affordable.
Arlington, VA—On Thursday, March 1, 2018, Management Sciences for Health (MSH) will host an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program. The event, under the theme, Toward Building Resilient Pharmaceutical Systems, will address progress made and opportunities toward ensuring that quality, life-saving essential medicines and services are available and affordable for the world’s poorest and most vulnerable.
Arlington, VA— A new compendium released today by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, implemented by Management Sciences for Health, offers an in-depth look at 12 innovative and promising efforts to strengthen pharmaceutical systems. Released via a new website, Case Studies in Pharmaceutical Systems Strengthening documents the lasting effect of interventions on the people, processes, and structures that comprise a pharmaceutical system and includes actionable lessons and recommendations.
Management Sciences for Health (MSH) announced today that it has been awarded a grant from the World Bank to advance health systems strengthening against non-communicable diseases (NCDs) in low- and middle-income countries (LMICs). The project will be led by MSH and joined by partners Research Triangle Institute (RTI) International and Global Health Insights (GLOHI).
Formerly known as the International Drug Price Indicator Guide, the revised publication includes more than 80 non-pharmaceutical products
The guide lists medical product prices on the international market
An essential reference for anyone involved in the procurement of medical products
Essential medicines, vaccines, immunologic agents, disinfectants, fluids and electrolytes, and diagnostic tests and agents are included
Global health NGO Management Sciences for Health (MSH) commends the collective efforts of 22 biopharma companies on the launch of "Access Accelerated," a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and lower-middle income countries.
Devex — in partnership with Management Sciences for Health — is launching Access to Medicines, a three week-long campaign that will analyze and amplify discussion on global access to medicines. The campaign will examine the challenges of access, identify how stakeholders can maximize investments and explore the future of medicine innovation in order to save lives, empower communities and build resilient health systems. Access to medicine is an essential piece to people-centered health care.
Access to Medicines: Join the Conversation with Devex and MSH
Health technology innovation to improve access and availability of essential medicines in South Africa
Johannesburg, South Africa—Management Science for Health (MSH), an international nonprofit dedicated to saving lives by building strong health systems in some of the world’s most vulnerable communities, today presented the government of South Africa with the source code for RxSolution®, an electronic pharmaceutical management system designed to manage medicine supplies from procurement to dispensing.